Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI R&D

R&D at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$336M-1.8%
Danaher logo
DanaherDHR
$387M+2.1%
Repligen logo
RepligenRGEN
$14.46M+19.3%
ADMA Biologics logo
ADMA BiologicsADMA
$2.6M+214%
Revvity logo
RevvityRVTY
$57.89M+8.0%
TEC
Bio-TechneTECH
$23.46M-4.6%

Segments

By segment

See full
TriLink$2.52M—
Cygnus$483K—

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s R&D?
Maravai LifeSciences Holdings, Inc. (MRVI) reported R&D of $3.89M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s R&D changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s R&D decreased by 20.4% year-over-year, from $4.89M to $3.89M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s R&D?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s R&D has grown at a 3.4% compound annual growth rate (CAGR), from $15.22M to $17.4M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.